Skip to content

Clinical trials

Phase 2 Hemophilia A trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Phase: Phase 2 Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20061
20071
20082
20092
20104
20141
20151
20174
20184
20191
20201
20222
20233
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated8
Unknown status2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
ApcinteX Ltd2
Bayer2
CSL Behring2
Kiminori Kimura, MD2
Novo Nordisk A/S2
Staidson (Beijing) Biopharmaceuticals Co., Ltd2
Suzhou Alphamab Co., Ltd.2
Ascension Healthcare Development Limited1
Carelon Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A34
Hemophilia B6
Liver Cirrhosis2
von Willebrand Diseases2
HIV Infections1
Hemorrhage1
Hemostatic Disorders1
Hepatitis1
Hepatitis C1
Renal Insufficiency1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.